Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management options for facial lipoatrophy.

Joseph Cofrancesco1, Todd Brown, Ciro R Martins

  • 1Johns Hopkins Lipodystrophy and Metabolic Complications Clinic, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

The AIDS Reader
|December 29, 2004
PubMed
Summary

Facial lipoatrophy in HIV patients has few effective treatments. Prevention and early recognition of subcutaneous fat loss are crucial, alongside careful selection of antiretroviral therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the Accreditation Council for Graduate Medical Education's Clinician Educator Milestones.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Epigenetic Aging and Treatment Response to Semaglutide in the SLIM LIVER Study.

Research square·2025
Same author

Trajectories of BMI Before, During, and After the COVID-19 Pandemic Among Participants in the MACS/WIHS Combined Cohort Study.

Journal of acquired immune deficiency syndromes (1999)·2025
Same author

Transforming individuals and institutions through competency-based faculty development.

Frontiers in medicine·2025
Same author

The association of payer type on genicular radiofrequency neurotomy treatment outcomes: Results of a cross-sectional study.

Interventional pain medicine·2024
Same author

Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Area of Science:

  • Medical Science
  • Dermatology
  • Infectious Diseases

Background:

  • Subcutaneous fat loss (lipoatrophy) is a growing concern in HIV-infected individuals.
  • Facial lipoatrophy significantly impacts patient quality of life.
  • Pathogenesis and metabolic links are increasingly understood, yet treatment options remain limited.

Purpose of the Study:

  • To review current understanding and treatment strategies for lipoatrophy in HIV patients.
  • To evaluate the efficacy and limitations of available interventions.
  • To emphasize the importance of prevention and early management.

Main Methods:

  • Literature review of antiretroviral therapy modifications, medications, and cosmetic procedures.
  • Analysis of treatment outcomes for facial lipoatrophy.

Related Experiment Videos

  • Discussion of the challenges associated with current interventions.

    • Main Results:

    • Switching highly active antiretroviral therapy (HAART) yields modest improvements.
    • Medications like rosiglitazone show conflicting and generally disappointing results.
    • Dermatologic and surgical interventions, including facial fillers, offer contour restoration but are costly and may have side effects.

    Conclusions:

    • Few effective treatments exist for established lipoatrophy.
    • Current interventions like fillers are expensive, require repeat application or may sag, and are often not covered by insurance.
    • Prevention, early detection, and optimized antiretroviral treatment selection are the most effective strategies.